fromwww.scientificamerican.com
1 day agoSurprise spinosaurid found, Moderna flu shot back on, multidisease vaxx shows promise
In a sudden turn of events last Wednesday the U.S. Food and Drug Administration agreed to review Moderna's new mRNA flu vaccine, according to the company. The announcement came roughly a week after Moderna revealed that the FDA had rejected its application. The company said the agency originally called the plan for the vaccine's phase 3 trials acceptable, But its position changed after top FDA official Vinay Prasad overruled the agency's reviewers, according to STAT.